Genetic modification of the human genome to resist HIV-1 infection and/or disease progression

Genetic modification of the human genome to resist HIV-1 infection and/or disease progression

Funding Type: 
SEED Grant
Grant Number: 
RS1-00172
Award Value: 
$616,800
Disease Focus: 
HIV/AIDS
Immune Disease
Stem Cell Use: 
Embryonic Stem Cell
Status: 
Closed
Public Abstract: 
Statement of Benefit to California: 
Progress Report: 

Year 1

The overall goal of this project is to investigate the use of embryonic stem cells and blood stem cells as a potential therapeutic approach for HIV-1 disease. We investigated a process known as RNA interference to block HIV-1 infection. We characterize the properties of cells carrying RNA interference to HIV-1 and developed new tools to facilitate the study.

© 2013 California Institute for Regenerative Medicine